Newsletter Subject

How to Legally Profit From LSD

From

energyandcapital.com

Email Address

newsletter@energyandcapital.com

Sent On

Thu, Jan 21, 2021 05:06 PM

Email Preheader Text

Most folks still think of LSD as a dangerous hallucinogenic drug, something for hippies and drug add

Most folks still think of LSD as a dangerous hallucinogenic drug, something for hippies and drug addicts. But what we’re finding now is that it could be one of the biggest, most disruptive medications the mental health industry has seen in 50 years. And with market disruption comes a huge opportunity to get rich. Most folks still think of LSD as a dangerous hallucinogenic drug, something for hippies and drug addicts. But what we’re finding now is that it could be one of the biggest, most disruptive medications the mental health industry has seen in 50 years. And with market disruption comes a huge opportunity to get rich. [Energy and Capital logo] How to Legally Profit From LSD [Jeff Siegel Photo] By [Jeff Siegel]( Written Jan 21, 2021 I was 17 when I first took LSD. To be honest, I didn’t like it. It kind of freaked me out. I was too young and inexperienced to fully understand what this molecule was and how it worked. I tried it again in college and then a few more times in my early 20s. Eventually, I did get to like it. Not to the point where I continued to use it, though. In fact, I haven’t taken LSD since the mid-'90s. Of course, I’m speaking about LSD from the perspective of a person who used it recreationally. But the truth is LSD is proving to be an amazingly effective treatment for everything from depression and anxiety to post-traumatic stress disorder and ADHD. At least that’s what the latest research is showing. Of course, most folks still think of LSD as a dangerous hallucinogenic drug, something for hippies and drug addicts. But what we’re finding now is that it could be one of the biggest, most disruptive medications the mental health industry has seen in 50 years. And with market disruption comes a huge opportunity to get rich. I will change your life in 29 days (guaranteed) If you give me 29 days, I guarantee to change your life. Too bold? During these next 29 days, I'm taking my 30-years of investing and will reveal my very best dividend investing strategies that will grow your account every single month. By Day 3: You'll buy and hold my 3 favorite stocks By Day 14: You'll automatically boost your dividend payouts with one button in your brokerage By Day 20: You'll discover a little-known contract to multiple dividends without buying another share By Day 29: You'll see how I triple my income in 10 minutes That's only the beginning too. [Learn more about it here.]( This LSD Company Is Already up 728% There are a number of psychedelics companies that are now researching LSD to be used for a variety of mental health issues. Perhaps the most well-known is MindMed (OTCBB: MMEDF). This is a company that’s developing a nonhallucinogenic form of LSD that can be used to treat ADHD and anxiety. If MindMed sounds familiar to you, it’s probably because I told you about it last year, before the stock soared 728%. Check it out… [newmindmed1] Members of my Green Chip Stocks community got in on my recommendation at $0.39. Today, the stock trades in excess of $3.00 a share. Now, while I know this is an impressive gain (and it’s not even close to how much this stock will be worth by the middle of this year), there’s a much bigger picture here. The #1 Weapon Against COVID-19 (NOT a Vaccine!) There’s a brand-new anti-COVID technology on the market. And it’s better than ANY vaccine. Tech giants like Apple, Microsoft, and Facebook are pouring every free dollar they have into this development. And get this — even Dr. Fauci is behind them! He’s admitted to using it himself. But best of all, Trump’s using the last few weeks of his presidency to make SURE it’s in every single airport across the country. The FDA has already approved two different COVID vaccines, but neither of them is easily accessible to the public. And that means this tech is the best chance we have of stopping this pandemic in its tracks. But the craziest part? One tiny company owns every single patent for the device. And right now, you can still pick up shares for under a dollar. But this profit window won’t last long, so you have to be quick. [Click here to get all the details on this breakthrough technology.]( Doing Well by Doing Good I’ve struggled with anxiety my entire life. I also have a lot of friends and family members who battle addiction on a daily basis. Sadly, some have actually lost that battle. So when I write to you about new psychedelics companies creating potentially life-changing treatments for various mental health conditions, understand that it’s bigger than just triple-digit gains. For me, it’s personal. And to be honest, I don’t think I know a single person who doesn’t struggle with anxiety, depression, or addiction — or at least know someone who does. It’s not a pretty picture. So when I do my due diligence on these companies, it’s actually something I really enjoy. I love seeing the latest research. I love interviewing people who have been cured of addiction and depression after taking part in clinical trials using these psychedelic molecules. Bottom line: It just feels really good to be able to make a boatload of cash by investing in companies that you know are making the world a better place by creating new treatments that are going to help so many people. And this is why I personally invested in MindMed, as well as a number of other psychedelics companies that are just crushing it right now. I’m happy to share this list with you, too. Just [click here]( to get access to that list. I should also note that in about a week or so, I’ll be recommending a new psychedelics stock that I believe will deliver similar gains to what we’ve already seen with MindMed. If you want me to email you the name of that company, just [click here]( and become a member of my Green Chip Stocks community today. To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel --------------------------------------------------------------- The $5 Stock Behind This $15 Trillion Breakthrough Over the last three years, a small, secretive company has been quietly filing 140 patents for a revolutionary technology. Forbes describes this technology as “transformative,” and big names are lining up to invest. When Jeff Bezos experienced this tech firsthand, he didn’t hesitate. He immediately invested a cool $116 million. But you don’t need to invest $116 million to reap the benefits of this once-in-a-lifetime opportunity. A modest $500 investment could be enough to bag you gains of as much as $1.5 million in the coming years. And it’s not as unbelievable as you think. If you had invested in a small Seattle tech company called Microsoft in 1986, you could have turned $500 into $1.1 million dollars. That’s a 237,400% return. Or what if you picked up 500 shares of McDonald’s back in 1965? You would have bagged gains of 68,270%. But the company I want to tell you about is doing something that is much more revolutionary than fast food or computers. In fact, I’ve just finished putting together a report that has all of the details on this little-known company, its revolutionary technology, and the 140 patents that will make it a household name. And I’m finally ready to share this free report with you. [Click here now to gain access to your report on the $5 stock behind this $15 trillion breakthrough...]( Browse Our Archives [The Most Valuable Trading Lesson I’ve Ever Learned]( [Pitfalls and Profits: SPAC Investing]( [IPO Market: Still Hot]( [The Truth About IPO Investing No One Is Telling You]( [How Non-Accredited Investors Can Profit From Public Offerings]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Energy and Capital](, Copyright © 2021, [Angel Publishing LLC](. All rights reserved. 3 E Read Street, Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Energy and Capital as well as a link to www.energyandcapital.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Energy and Capital]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Angel Publishing may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.

EDM Keywords (209)

young year write would worth world worked well weeks week want view variety vaccine using used use us unbelievable truth trump triple tried transformative tracks told times though think telling tell technology tech taking sure subscription struggled struggle stopping stock statement speaking sources something solicitation showing shares share sent sell seen see security securities sale right revolutionary reviewing reveal republished report reliable recreationally recommending recommendation received receive reap question purchase publisher publication public proving prospectus profit probably privacy presidency point picked perspective personal person pandemic opinion one offer number neither need name much molecule mindmed middle member means mcdonald may market manage making make made lsd lot list link lining like life least learn last know kind investment investing invested invest intention information inexperienced indirectly income important honest hold hippies hesitate help happy guarantee grow good going give get gains friends freaked finding fda fact facebook expression excess everything ensure enough energy email editors dollar discover device development developing details depression decrease cured crushing course country could continued content consulting consultants computers company companies college click change cash capital buy brokerage bold boatload biggest bigger better best benefits believe behind beginning become battle bag back author archives anyone anxiety also already admitted adhd addiction accuracy able 728 1986 1965 17

Marketing emails from energyandcapital.com

View More
Sent On

08/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

04/12/2024

Sent On

04/12/2024

Sent On

02/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.